Key Opinion Leader Relationship and Speaker Bureau Management at Leading Pharmaceutical Companies in the United States
 
New Page 1

This innovative study examines how leading pharmaceutical and biotech companies manage their key opinion leader (KOL) relationships. The study includes the following:

  • Description of how various internal constituencies (sales reps, medical liaisons, clinical research associates, etc.) interact with KOLs
  • Typical perks offered to KOLS
    • Research fees
    • Access to company data/resources
    • Other
  • Trends in the relationship model, including impact of PhRMA guidelines and use of personnel beyond medical liaisons to interact with these individuals
  • CRM software systems used with KOLs
  • Key metrics utilized to evaluate KOL effectiveness
  • Use of social influencing mapping to guide KOL tactical planning
  • Honoraria levels for KOLs
    • National
    • Regional
    • Local

To receive more information about the study, including a list of companies analyzed and sample pages, click on the Contact Us link.